What We're Reading: Taxpayers Spending Millions on Expensive Generic Drugs
What we're reading, December 18, 2015: HHS report finds generic drug prices rising faster than inflation; UnitedHealthcare's real-time drug approval tool; and government overcharged by private Medicare Advantage plans.
A report released by HHS, based on their investigation of rising generic drug prices, has found that
UnitedHealthcare is collaborating with providers to offer them a fast-track drug approval process that is almost real-time.
Records from CMS reveal that private Medicare Advantage plans continued to overcharge the government millions of dollars, despite officials within CMS drawing attention to this fraud as early as 2008. According to a
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025